medicare

Two Stocks in My Favorite Industry Sector

The Dow Jones has been zigzagging nearly all year long. Everyone knows that.Transportation stocks, basic materials and commodities have been sagging, even plunging. Most people know that, too.What many people may not be aware of — or may be underestimating — is the strength and sustainability of one key sector that’s been making investors money through thick and thin: health […]

Biotech Stocks: Safe vs Sexy – Stocks to Watch – Barrons.com

By Johanna BennettDo you want safe, or sexy?That’s the question facing biotechnology investors, according to a recent research note from Cowen analysts that previews the sector’s second-quarter financial results.“In heady times, large cap provides a safe haven, smid caps the sex appeal,” reads the note.After shrugging off a selloff in late June, the Nasdaq Biotechnology index has gained 30% since […]

Biotech Stocks: Safe vs Sexy

By Johanna BennettDo you want safe, or sexy?That’s the question facing biotechnology investors, according to a recent research note from Cowen analysts that previews the sector’s second-quarter financial results.“In heady times, large cap provides a safe haven, smid caps the sex appeal,” reads the note.After shrugging off a selloff in late June, the Nasdaq Biotechnology index has gained 30% since […]

Headwinds Could Blunt Long-Running Rally In Health Care Stocks

Guest post written byPaul KarosPaul Karos is a senior portfolio manager at Minneapolis-based Whitebox Advisors, which manages over $4 billion in hedge and mutual funds.Health care stocks have enjoyed a persistent bid in the markets over the past three years. Health care was second best performing sector in the S&P 500 during the choppy markets of 2014 (up 23%, […]

Cyberonics shares drop after Medicare appeal denied

SAN FRANCISCO (MarketWatch) — Cyberonics Inc. shares declined in the extended session Monday after the medical device maker said its appeal of a medical reimbursement decision was denied.Cyberonics CYBX, +5.49% shares fell 8.1% to $53.10 on moderate volume after an appeals board supported a 2007 decision by the Centers for Medicare and Medicaid that the company’s pacemaker-like device for treating […]